1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Bioprocess Containers Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Bioprocess Containers Market Analysis and Forecast, 2017-2033
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Technological Advancements
5.2. Key Industry Events
5.3. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)
6. Global Bioprocess Containers Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Type, 2017-2033
6.3.1. 2D Bioprocess Containers
6.3.2. 3D Bioprocess Containers
6.3.3. Others
6.4. Market Attractiveness Analysis, by Type
7. Global Bioprocess Containers Market Analysis and Forecast, by Capacity
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Capacity, 2017-2033
7.3.1. Small Volume
7.3.2. Large Volume
7.4. Market Attractiveness Analysis, by Capacity
8. Global Bioprocess Containers Market Analysis and Forecast, by Application
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Application, 2017-2033
8.3.1. Upstream Processes
8.3.2. Downstream Processes
8.3.3. Process Development
8.4. Market Attractiveness Analysis, by Application
9. Global Bioprocess Containers Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast, by End-user, 2017-2033
9.3.1. Pharmaceutical & Biotechnology Companies
9.3.2. CROs & CMOs
9.3.3. Academic & Research Institutes
9.4. Market Attractiveness Analysis, by End-user
10. Global Bioprocess Containers Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness Analysis, by Region
11. North America Bioprocess Containers Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Type, 2017-2033
11.2.1. 2D Bioprocess Containers
11.2.2. 3D Bioprocess Containers
11.2.3. Others
11.3. Market Value Forecast, by Capacity, 2017-2033
11.3.1. Small Volume
11.3.2. Large Volume
11.4. Market Value Forecast, by Application, 2017-2033
11.4.1. Upstream Processes
11.4.2. Downstream Processes
11.4.3. Process Development
11.5. Market Value Forecast, by End-user, 2017-2033
11.5.1. Pharmaceutical & Biotechnology Companies
11.5.2. CROs & CMOs
11.5.3. Academic & Research Institutes
11.6. Market Value Forecast, by Country, 2017-2033
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Type
11.7.2. By Capacity
11.7.3. By Application
11.7.4. By End-user
11.7.5. By Country
12. Europe Bioprocess Containers Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Type, 2017-2033
12.2.1. 2D Bioprocess Containers
12.2.2. 3D Bioprocess Containers
12.2.3. Others
12.3. Market Value Forecast, by Capacity, 2017-2033
12.3.1. Small Volume
12.3.2. Large Volume
12.4. Market Value Forecast, by Application, 2017-2033
12.4.1. Upstream Processes
12.4.2. Downstream Processes
12.4.3. Process Development
12.5. Market Value Forecast, by End-user, 2017-2033
12.5.1. Pharmaceutical & Biotechnology Companies
12.5.2. CROs & CMOs
12.5.3. Academic & Research Institutes
12.6. Market Value Forecast, by Country/Sub-region, 2017-2033
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Italy
12.6.5. Spain
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Type
12.7.2. By Capacity
12.7.3. By Application
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Bioprocess Containers Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Type, 2017-2033
13.2.1. 2D Bioprocess Containers
13.2.2. 3D Bioprocess Containers
13.2.3. Others
13.3. Market Value Forecast, by Capacity, 2017-2033
13.3.1. Small Volume
13.3.2. Large Volume
13.4. Market Value Forecast, by Application, 2017-2033
13.4.1. Upstream Processes
13.4.2. Downstream Processes
13.4.3. Process Development
13.5. Market Value Forecast, by End-user, 2017-2033
13.5.1. Pharmaceutical & Biotechnology Companies
13.5.2. CROs & CMOs
13.5.3. Academic & Research Institutes
13.6. Market Value Forecast, by Country/Sub-region, 2017-2033
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Type
13.7.2. By Capacity
13.7.3. By Application
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Bioprocess Containers Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Type, 2017-2033
14.2.1. 2D Bioprocess Containers
14.2.2. 3D Bioprocess Containers
14.2.3. Others
14.3. Market Value Forecast, by Capacity, 2017-2033
14.3.1. Small Volume
14.3.2. Large Volume
14.4. Market Value Forecast, by Application, 2017-2033
14.4.1. Upstream Processes
14.4.2. Downstream Processes
14.4.3. Process Development
14.5. Market Value Forecast, by End-user, 2017-2033
14.5.1. Pharmaceutical & Biotechnology Companies
14.5.2. CROs & CMOs
14.5.3. Academic & Research Institutes
14.6. Market Value Forecast, by Country/Sub-region, 2017-2033
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Type
14.7.2. By Capacity
14.7.3. By Application
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Bioprocess Containers Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Type, 2017-2033
15.2.1. 2D Bioprocess Containers
15.2.2. 3D Bioprocess Containers
15.2.3. Others
15.3. Market Value Forecast, by Capacity, 2017-2033
15.3.1. Small Volume
15.3.2. Large Volume
15.4. Market Value Forecast, by Application, 2017-2033
15.4.1. Upstream Processes
15.4.2. Downstream Processes
15.4.3. Process Development
15.5. Market Value Forecast, by End-user, 2017-2033
15.5.1. Pharmaceutical & Biotechnology Companies
15.5.2. CROs & CMOs
15.5.3. Academic & Research Institutes
15.6. Market Value Forecast, by Country/Sub-region, 2017-2033
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Type
15.7.2. By Capacity
15.7.3. By Application
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player – Competition Matrix (By Tier and Size of companies)
16.2. Market Share Analysis By Company (2022)
16.3. Company Profiles
16.3.1. Sartorius AG
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Thermo Fisher Scientific Inc.
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Danaher Corporation
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Merck KGaA
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Corning Incorporated
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Saint-Gobain
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Avantor, Inc.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. Parker Hannifin Corporation
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. Entegris, Inc.
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. Meissner Filtration Products, Inc.
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. Financial Overview
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview
16.3.11. Lonza AG
16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.11.2. Product Portfolio
16.3.11.3. Financial Overview
16.3.11.4. SWOT Analysis
16.3.11.5. Strategic Overview
16.3.12. Flexbiosys Inc.
16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.12.2. Product Portfolio
16.3.12.3. Financial Overview
16.3.12.4. SWOT Analysis
16.3.12.5. Strategic Overview
16.3.13. ABEC, Inc.
16.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.13.2. Product Portfolio
16.3.13.3. Financial Overview
16.3.13.4. SWOT Analysis
16.3.13.5. Strategic Overview
16.3.14. Cellexus
16.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.14.2. Product Portfolio
16.3.14.3. Financial Overview
16.3.14.4. SWOT Analysis
16.3.14.5. Strategic Overview
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
